These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3826966)

  • 21. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis.
    Porter D; Madhok R; Hunter JA; Capell HA
    Ann Rheum Dis; 1992 Apr; 51(4):461-4. PubMed ID: 1350192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Auranofin-associated colitis and eosinophilia.
    Michet CJ; Rakela J; Luthra HS
    Mayo Clin Proc; 1987 Feb; 62(2):142-4. PubMed ID: 3807438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature.
    Langer HE; Hartmann G; Heinemann G; Richter K
    Ann Rheum Dis; 1987 Oct; 46(10):787-92. PubMed ID: 3318725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Well controlled comparative study in early rheumatoid arthritis with gold sodium thiomalate vs. auranofin].
    Yamamoto S; Mitomo N; Saito T; Nishioka K; Inoue K; Uchida S; Ohata N; Murasawa A; Suzuki A; Mitsui T
    Ryumachi; 1990 Feb; 30(1):26-44. PubMed ID: 2116042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Long-term therapy with gold salts in rheumatoid arthritis. Review of the literature and personal contribution].
    Copertari N; Cordioli E; Martinelli M
    Minerva Med; 1993 May; 84(5):219-25. PubMed ID: 8316339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the clinico-therapeutic response to oral gold salts in patients with rheumatoid arthritis].
    Giordano N; Biasi G; Morozzi G; Taddeo A; Frati E; Marcolongo R; Paternò E
    Clin Ter; 1989 Mar; 128(5):343-6. PubMed ID: 2524321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.
    Borg G; Allander E; Berg E; Brodin U; From A; Trang L
    J Rheumatol; 1991 Jul; 18(7):1015-20. PubMed ID: 1920306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythrocyte membrane gold levels after treatment with auranofin and sodium aurothiomalate.
    Iqbal MS; Saeed M; Taqi SG
    Biol Trace Elem Res; 2008; 126(1-3):56-64. PubMed ID: 18649049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin.
    Caruso I; Santandrea S; Sarzi Puttini P; Montrone F; Boccassini L; Azzolini V; Cazzola M; Dell'Acqua D
    J Int Med Res; 1992 Feb; 20(1):61-77. PubMed ID: 1568521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
    Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
    J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucocutaneous toxicity of gold salts by parenteral administration--rechallenge with auranofin.
    Tumiati B; Veneziani M; Bellelli A; Portioli I
    J Rheumatol; 1987 Feb; 14(1):177. PubMed ID: 2952794
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of gold salts in Still's disease].
    Moccia F; Morra L
    Clin Ter; 1988 Dec; 127(6):431-4. PubMed ID: 2977316
    [No Abstract]   [Full Text] [Related]  

  • 35. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenging the pyramid. A new look at therapeutic approaches for rheumatoid arthritis. Earlier intervention with second line therapies.
    Ward JR
    J Rheumatol Suppl; 1990 Nov; 25():18-23. PubMed ID: 1980313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Auranofin: first choice for remission-inducing drug (RID) therapy in rheumatoid arthritis?
    Bandilla K; Missler B; Klein-Reesink B
    Scand J Rheumatol Suppl; 1986; 63():47-54. PubMed ID: 3474777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The potentials of a peroral gold preparation (Ridaura) in treating rheumatoid arthritis based on prospective observation data].
    Slobodina GA; Kanevskaia MZ; Krel' AA; Chichasova NV; Pokryshkin VI
    Ter Arkh; 1988; 60(12):80-4. PubMed ID: 3247662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis.
    Champion GD; Cairns DR; Bieri D; Adena MA; Browne CD; Cohen ML; Day RO; Edmonds JP; Graham GG; de Jager J
    J Rheumatol; 1988 Jan; 15(1):28-34. PubMed ID: 3280795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.